Fritextsökning
Innehållstyper
-
Diamyd startar studie
Bolagets diabetesvaccin testas på amerikanska barn med typ 1-diabetes.
-
Age essential when testing drugs
Anders Rane has been arguing that genes and age are both important factors in understanding how medicines affect individuals. Only last year, the EU established...
-
Biotage is regrouping
The Swedish company Biotage takes yet another step in streamlining efforts, by outsourcing all instrument production to contract manufacturers.
-
Vitamin D is mental health aid
Vitamin D can help stave off the mental decline that can affect people in old age, a study suggests.
-
DKK 1,3 billion for grand research
Danish Councils for Independent Research, DFF, will grant DKK 1,3 billion during 2009. Now has the application period started.
-
Stockholm-Uppsala life science cluster in brief
Stockholm-Uppsala evolves around the research at Karolinska Institutet and Uppsala University. Typical areas of research are protein research, neuroscience and cancer.
-
Nio etablerade forskare får EU-anslag
Passagereglering i blod-hjärnbarriären, riskfaktorer kring cancer och proteomanalyser är några forskningsområden som får anslag från Advanced Grant-programmet.
-
Lundbeck divests companies
The company sells all shares in one listed company plus divests four small private equity funds, for a three-figured million sum.
-
Astras kolläkemedel in i fas III
Astrazenecas läkemedelskandidat benralizumab uppvisar positiva resultat i en fas II-studie och går in i fas III.
-
Prisar kvinnliga forskare
Kristiina Tammimies och Annica Black-Schaffer är de första svenska forskarna att tilldelas det nya priset L’Oréal-Unesco For Women in Science.
-
Academy for a new turn at work
Are you qualified within life science, but unemployed? Here is your chance for a new career, in high demand.
-
Orion cuts 205 jobs
The Finnish company Orion has completed its statutory negotiations. By this, personnel will be reduced by about 205 in Finland.
-
Unikt program för doktorander
Ämnesinriktningen för doktorandprogrammet i Lund är cancerforskning men här står även entreprenörskap och förståelse för klinisk praxis på schemat.
-
Parnevik firm in Swiss osteoporosis deal
The golf legend Jesper Parnevik's drug delivery firm EffRx has signed a license agreement with Nycomed for a new drug against osteoporosis.
-
Framtidens digitala sjukvård
Elektronisk hälsoinformatik är avgörande för utvecklingen av hälso- och sjukvård. Att investera i teknik som uppnår kostnadsbesparingar genom förbättrad patient...
-
Otto Cars får pris
Otto Cars prisas med APUA Leadership Award för sitt engagemang för att förebygga antibiotikaresistens.
-
Acadia drug awarded
Acadia Pharmaceutical has got an award for a new treatment against Parkinson's disease.
-
Teams up with leading dermatologist
Tripep has signed a letter of intent with a major Japanese specialty pharma company to bring their wound healing treatment to a big market.
-
Respiratorius hunts millions
The biopharmaceutical company Respiratorius has got a new CEO, who starts a public new share issue to catch almost SEK ten million.
-
SDU professor helps EU
Mette Præst Knudsen from the University of Southern Denmark, SDU, has been appointed as an expert member in an EU politics group.
-
Grape extract kills cancer cells
Grapes contain potentially beneficial chemicals that can destroy cancer cells, a new research proves.
-
Orexo opens doors eastwards
The drug delivery company has signed a deal for selling a cancer pain treatment in China. "An ideal partner for us" says Torbjörn Bjerke, CEO of Orexo.
-
Cate Poulsen, Qiagen
Why are you going to Scanlab and Biotech Forum?
-
New study of toxins and heart disease
Is there a correlation between exposure to hormone interfering environmental toxins and increased risk of developing cardiovascular disease? A new patient study...